

Three recent randomised controlled trials (RCTs)—two of which were published in The Lancet Gastroenterology & Hepatology—have defined endoscopic ultrasonography-guided gastroenterostomy as a transformative advance for malignant gastric outlet obstruction.1–3 Each trial represents a major technical and methodological accomplishment, collectively positioning endoscopic ultrasonography-guided gastroenterostomy as a credible and increasingly accessible alternative to surgical bypass or duodenal stent palliation.
Gastroenterology & Hepatology
|15th Jan, 2026
|The Lancet
Gastroenterology & Hepatology
|15th Jan, 2026
|The Lancet
Gastroenterology & Hepatology
|15th Jan, 2026
|The Lancet
Gastroenterology & Hepatology
|15th Jan, 2026
|The Lancet
Gastroenterology & Hepatology
|15th Jan, 2026
|The Lancet
Gastroenterology & Hepatology
|15th Jan, 2026
|The Lancet
Gastroenterology & Hepatology
|15th Jan, 2026
|The Lancet